Kura Oncology (KURA) Interest Expenses (2010 - 2026)
Kura Oncology (KURA) reported Interest Expenses of $336000.0 for Q1 2026, down 12.04% year-over-year from $382000.0 in Q1 2025, and down 2.89% on a QoQ basis from $346000.0 in Q4 2025.
Kura Oncology (KURA) has 16 years of Interest Expenses data on file, last reported at $336000.0 in Q1 2026.
- Quarterly Interest Expenses fell 12.04% year-over-year to $336000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 8.55% YoY) and the FY2025 annual result came in at $1.5 million, down 6.61% from the prior year.
- Interest Expenses eased to $336000.0 in Q1 2026 per KURA's latest filing, from $346000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $412000.0 in Q3 2024 and bottomed at $336000.0 in Q1 2026.
- The 4-year median for Interest Expenses is $393000.0 (2025), against an average of $385846.2.
- The widest annual swing landed in 2024, when Interest Expenses grew 9.34%; it then slipped 14.14% in 2025.
- Tracing KURA's Interest Expenses over 4 years: stood at $394000.0 in 2023, then advanced by 2.28% to $403000.0 in 2024, then fell by 14.14% to $346000.0 in 2025, then decreased by 2.89% to $336000.0 in 2026.
- Per Business Quant, the three latest KURA Interest Expenses figures stand at $336000.0 (Q1 2026), $346000.0 (Q4 2025), and $393000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 336,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 336,000.00 |
| Mar 31, 2026 | 336,000.00 |
| Dec 31, 2025 | 346,000.00 |
| Dec 31, 2025 | 346,000.00 |
| Sep 30, 2025 | 393,000.00 |
| Sep 30, 2025 | 393,000.00 |
| Jun 30, 2025 | 391,000.00 |
| Jun 30, 2025 | 391,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Dec 31, 2024 | 403,000.00 |
| Dec 31, 2024 | 403,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Jun 30, 2024 | 406,000.00 |
| Jun 30, 2024 | 406,000.00 |
| Mar 31, 2024 | 398,000.00 |
| Mar 31, 2024 | 398,000.00 |
| Dec 31, 2023 | 394,000.00 |
| Dec 31, 2023 | 394,000.00 |
| Sep 30, 2023 | 404,000.00 |
| Sep 30, 2023 | 404,000.00 |
| Jun 30, 2023 | 387,000.00 |
| Jun 30, 2023 | 387,000.00 |
| Mar 31, 2023 | 364,000.00 |
| Mar 31, 2023 | 364,000.00 |
| Jun 30, 2021 | 306,000.00 |
| Jun 30, 2021 | 306,000.00 |
| Mar 31, 2021 | 108,000.00 |
| Mar 31, 2021 | 108,000.00 |
| Dec 31, 2020 | 144,000.00 |
| Dec 31, 2020 | 144,000.00 |
| Sep 30, 2020 | 146,000.00 |
| Sep 30, 2020 | 146,000.00 |
| Jun 30, 2020 | 144,000.00 |
| Jun 30, 2020 | 144,000.00 |
| Mar 31, 2020 | 144,000.00 |
| Mar 31, 2020 | 144,000.00 |
| Dec 31, 2019 | 142,000.00 |
| Dec 31, 2019 | 142,000.00 |
| Sep 30, 2019 | 145,000.00 |
| Sep 30, 2019 | 145,000.00 |
| Jun 30, 2019 | 148,000.00 |
| Jun 30, 2019 | 148,000.00 |
| Mar 31, 2019 | 145,000.00 |
| Mar 31, 2019 | 145,000.00 |
| Dec 31, 2018 | 193,000.00 |
| Dec 31, 2018 | 193,000.00 |
| Sep 30, 2018 | 252,000.00 |
| Sep 30, 2018 | 252,000.00 |
| Jun 30, 2018 | 267,000.00 |
| Jun 30, 2018 | 267,000.00 |
| Mar 31, 2018 | 258,000.00 |
| Mar 31, 2018 | 258,000.00 |
| Dec 31, 2017 | 250,000.00 |
| Dec 31, 2017 | 250,000.00 |
| Sep 30, 2017 | 226,000.00 |
| Sep 30, 2017 | 226,000.00 |
| Jun 30, 2017 | 209,000.00 |
| Jun 30, 2017 | 209,000.00 |
| Mar 31, 2017 | 203,000.00 |
| Mar 31, 2017 | 203,000.00 |
| Dec 31, 2016 | 194,000.00 |
| Dec 31, 2016 | 194,000.00 |
| Sep 30, 2016 | 194,000.00 |
| Sep 30, 2016 | 194,000.00 |
| Jun 30, 2016 | 189,000.00 |
| Jun 30, 2016 | 189,000.00 |
| Mar 31, 2015 | 46,000.00 |
| Mar 31, 2015 | 46,000.00 |
| Dec 31, 2014 | 37,000.00 |
| Dec 31, 2014 | 37,000.00 |
| Sep 30, 2014 | 1,664.00 |
| Sep 30, 2014 | 1,664.00 |
| Jun 30, 2014 | 1,645.00 |
| Jun 30, 2014 | 1,645.00 |
| Mar 31, 2014 | 1,628.00 |
| Mar 31, 2014 | 1,628.00 |
| Dec 31, 2013 | 1,663.00 |
| Dec 31, 2013 | 1,663.00 |
| Sep 30, 2013 | 1,664.00 |
| Sep 30, 2013 | 1,664.00 |
| Jun 30, 2013 | 1,293.00 |
| Jun 30, 2013 | 1,293.00 |
| Mar 31, 2013 | 1,257.00 |
| Mar 31, 2013 | 1,257.00 |
| Dec 31, 2012 | 1,286.00 |
| Dec 31, 2012 | 1,286.00 |
| Sep 30, 2012 | 1,285.00 |
| Sep 30, 2012 | 1,285.00 |
| Jun 30, 2012 | 1,272.00 |
| Jun 30, 2012 | 1,272.00 |
| Mar 31, 2012 | 1,131.00 |
| Mar 31, 2012 | 1,131.00 |
| Dec 31, 2011 | 908.00 |
| Dec 31, 2011 | 908.00 |
| Sep 30, 2011 | 907.00 |
| Sep 30, 2011 | 907.00 |
| Jun 30, 2011 | 898.00 |
| Jun 30, 2011 | 898.00 |
| Mar 31, 2011 | 888.00 |
| Mar 31, 2011 | 888.00 |
| Dec 31, 2010 | 532.00 |
| Dec 31, 2010 | 532.00 |
| Sep 30, 2010 | 529.00 |
| Sep 30, 2010 | 529.00 |